0 Комментарии
0 Поделились
1004 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Antihyperlipidemic Drugs Market, analysis Outlook, Trend, Growth And Share Estimation Analysis To 2031The global Antihyperlipidemic Drugs market is estimated to attain a valuation of US$ 20.1 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.1% during the forecast period, 2022-2031. The key objective of the TMR report is to offer a complete assessment of the global market...0 Комментарии 0 Поделились 1575 Просмотры 0 предпросмотр
- Antihyperlipidemic Drugs: Effective medications to manage high cholesterol levelsHyperlipidemia or high cholesterol is a condition where excessive amounts of lipids (fats) accumulate in the blood. This can increase the risks of cardiovascular diseases like heart attack and stroke. Lifestyle modifications like dietary changes and exercise can help control cholesterol levels to some extent. However, medications are often required to bring cholesterol values down to the...0 Комментарии 0 Поделились 1062 Просмотры 0 предпросмотр
- Global Antihyperlipidemic Drugs Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cardiovascular DiseasesThe Antihyperlipidemic Drugs Market is estimated to be valued at US$ 12.6 Bn in 2022 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Antihyperlipidemic drugs are used to lower and control the levels of lipids, such as cholesterol and triglycerides, in the blood. These drugs are...0 Комментарии 0 Поделились 873 Просмотры 0 предпросмотр
- Pharmaceutical Drugs (Statins) Is The Largest Segment Driving The Growth Of Antihyperlipidemic Drugs MarketSWOT Analysis Strengths: Drugs in this market such as statins are highly effective in lowering LDL cholesterol levels and reducing the risk of heart attacks and strokes. The market comprises several major pharmaceutical players with wide distribution networks. Weaknesses: Statins have certain side effects such as muscle pain and are not suitable for all patients. Generic competition has eroded...0 Комментарии 0 Поделились 840 Просмотры 0 предпросмотр
- The Antihyperlipidemic Drugs Market is poised to witness high growth owing to Increasing Prevalence of ObesityThe global Antihyperlipidemic Drugs Market is estimated to be valued at US$ 13.6 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Antihyperlipidemic drugs are commonly known as lipid lowering drugs or statins which reduce cholesterol and triglyceride levels in the blood. These...0 Комментарии 0 Поделились 607 Просмотры 0 предпросмотр